UNSPSC 51452800: Anthelmintic macrolides

Anthelmintic drugs made from a group of often glycosylated macrocyclic compounds formed by chain extension of multiple propionates cyclized into a large (typically 12, 14, or 16)-membered lactone.

UNSPSC 51452800 Anthelmintic macrolides is a Class code that shows substantial mismatch between its nominal scope and recent state and local procurement activity. The code's taxonomic label refers to antiparasitic macrolide compounds used in veterinary and human medicine, yet recent opportunities posted under this code reflect broad pharmaceutical procurement spanning naloxone, generic multi-source drugs, over-the-counter products, and direct-to-manufacturer prescription programs. State and local issuing bodies are using the code to solicit medical supplies, emergency-response pharmaceuticals, and wholesale pharmacy benefit services rather than anthelmintic compounds specifically. The work actually being bought includes emergency naloxone and drug deactivation systems for county health initiatives, medical and first aid supplies for fire department rescue operations, generic pharmaceuticals and OTC products through cooperative purchasing alliances, and therapeutic pharmacy initiatives seeking direct manufacturer relationships outside traditional pharmacy benefit manager networks. Issuing bodies span county health departments, municipal fire departments, state health and human services agencies, and multistate cooperative purchasing organizations coordinating across multiple jurisdictions.

Recent opportunities show geographic spread across Florida, Texas, and Minnesota, with multistate reach through cooperative purchasing vehicles. Seminole County, Florida solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through IFB 60459723LAS (due July 26, 2023), with quarterly deliveries to the Seminole County Community Health Building. The City of Tampa issued Bid 26-P-00145 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division (due March 13, 2026), estimated at $700,000 and sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities including Oregon (due March 26, 2026). The Texas Health and Human Services Commission posted RFI HHS0017013 (due April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements. The code's recent activity reflects pharmaceutical distribution and emergency-response supply procurement rather than anthelmintic-specific sourcing, signaling either broad categorization drift or a taxonomy alignment issue in state and local systems.